Paloma Partners Management CO Lexicon Pharmaceuticals, Inc. Transaction History

Paloma Partners Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.44 - $2.1 $35,988 - $52,483	-24,992 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $43,736 - $57,481	24,992 New	24,992 $50,000
Q4 2019 Feb 14, 2020	SELL	$3.16 - $5.15 $135,248 - $220,420	-42,800 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $51,360 - $285,048	42,800 New	42,800 $129,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $85,081 - $113,070	-15,903 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $21,377 - $38,929	4,903 Added 44.57%	15,903 $88,000
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $67,650 - $115,610	11,000 New	11,000 $73,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $609,699 - $853,717	-69,521 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $846,070 - $1.13 Million	69,521	69,521 $854,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.